ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 3,625,000 Value ($000) $5,473 Avg Close — Range —
Q1 2025
Shares 8,449,000 Value ($000) $9,984 Avg Close — Range —
Q4 2024
Shares 15,738,000 Value ($000) $17,408 Avg Close — Range —
Q3 2024
Shares 14,132,000 Value ($000) $16,843 Avg Close — Range —
Q2 2024
Shares 18,227,000 Value ($000) $20,253 Avg Close — Range —
Q1 2024
Shares 16,393,000 Value ($000) $15,901 Avg Close — Range —
Q4 2023
Shares 14,290,000 Value ($000) $14,369 Avg Close — Range —
Q3 2023
Shares 15,878,000 Value ($000) $14,955 Avg Close — Range —